𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification and characterization of a novel nonsecosteroidal vitamin D receptor ligand

✍ Scribed by Fang Chen; Qin Su; Maricel Torrent; Nan Wei; Norbert Peekhaus; Daniel McMasters; John Fisher; Helmut Glantschnig; Paul Hodor; Osvaldo Flores; Alfred Reszka


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
275 KB
Volume
68
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

✦ Synopsis


Vitamin D receptor (VDR)

and its ligands play important roles in mineral/skeletal homeostasis, cell proliferation/differentiation, and modulation of immune responses. VDR ligands make attractive candidates for the treatment/prevention of osteoporosis, psoriasis, and cancer. The major issue with current analogs is hypercalcemia. As nonsteroidal therapeutic agents with fewer side effects have been made for androgen and estrogen receptors, nonsecosteroidal VDR ligands possessing beneficial effects may also be possible. Here we present a novel podocarpic acid-based nonsecosteroidal VDR ligand (VDRL-1). VDRL-1 bound to VDR with a Ki of $1.3 mM in competition binding assays. Data from binding and molecular docking suggest that VDRL-1 interacts with the same binding pocket as 1a,25-(OH) 2 vitamin D 3 (1,25-D 3 ). In cell-based transcription assays, VDRL-1 reached the same maximal activity as 1,25-D 3 , albeit with an EC 50 $1.0 mM. Likewise, VDRL-1 was a full agonist in suppressing proliferation of several human cancer cells. Microarrays demonstrated that VDRL-1 exerted a near identical expression pattern to that of 1,25-D 3 in several human cancer cells. Taqman analysis of known and novel VDR-regulated genes showed that VDRL-1 was a full agonist on osteocalcin (OC), CYP24A1, and other genes. It exerted partial agonist activity on G0/ G1 switch gene 2 (G0S2). Furthermore, VDRL-1 could be a full or partial agonist of calcium transporter 1 (TRPV6) expression and partially antagonized 1,25-D 3 in cells where it partially regulated TRPV6. Thus, the current study describes a novel nonsecosteroidal VDR ligand that behaves mostly like 1,25-D 3 , but possesses unique characteristics.


πŸ“œ SIMILAR VOLUMES


A nonsecosteroidal vitamin D receptor li
✍ Masahiko Sato; Jianliang Lu; Stephen Iturria; Keith R Stayrook; Lorri L Burris; πŸ“‚ Article πŸ“… 2010 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 271 KB

Vitamin D(3) analogues were shown to be beneficial for osteoporosis and other indications, but their narrow therapeutic window between efficacy and hypercalcemia has limited their clinical utility. A nonsecosteroidal, tissue-selective, orally bioavailable, vitamin D receptor (VDR) ligand was ascerta

Isolation and characterization of the ch
✍ Zhongjian Lu; Frederic Jehan; Claudia Zierold; Hector F. DeLuca πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 165 KB

The sequences from several independent cDNA clones encoding the chicken vitamin D receptor as well as primer extension assay have clearly delineated the 5Ј terminus and the transcriptional start site. Screening a chicken genomic library produced genomic clones containing vitamin D receptor (VDR) gen

Identification and characterization of a
✍ Wanjin Hong; Anh Van Le; Darrell Doyle πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 687 KB

The asialoglycoprotein receptor, the hepatic binding lectin for galactose-terminated glycoproteins, has been isolated and characterized from human, rabbit and rat liver. Several recent studies have shown the existence of the same receptor in murine liver. However, the biochemical structure of the re